 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from scanned originals with text recognition applied 
(searchable text may contain so me errors and/or omissions) 
 
 
1 
2 Date: '--//7/ / 7 L.D. 6 
(Filing No. S-2 Z ) 
3 INSURANCE AND FINANCIAL SERVICES 
4 Reproduced and distributed under the direction of the Secretary of the Senate. 
5 STATE OF MAINE 
6 SENATE 
7 128TH LEGISLATURE 
8 FIRST REGULAR SESSION 
9 COMMITTEE AMENDMENT" A" to S.P. 10, L.D. 6, Bill, "An Act To Prohibit 
10 Insurance Carriers from Retroactively Reducing Payment on Clean Claims Submitted by 
11 Pharmacies" 
12 Amend the bill by striking out the title and substituting the following: 
13 'An Act To Prohibit Insurance Carriers from Charging Enrollees for Prescription 
14 Drugs in Amounts That Exceed the Drugs' Costs' 
15 Amend the bill by striking out everything after the enacting clause and before the 
16 summary and inserting the following: 
17 'Sec. 1. 24-A MRSA ยง4317, sub-ยง13 is enacted to read: 
18 13. Prohibition on excessive copayments or charges; disclosure not penalized. A 
19 carrier or pharmacy benefits manager may not impose on an enrollee a copayment or 
20 other charge that exceeds the claim cost of a prescription drug. If information related to 
21 the cost or clinical efficacy of a prescription drug or alternative medication is available to 
22 a pharmacy provider, a carrier or pharmacy benefits manager may not penalize a 
23 pharmacy provider for providing that information to an enrollee.' 
24 SUMMARY 
25 This amendment replaces the bill and changes the title. The amendment prohibits a 
26 carrier or pharmacy benefits manager from imposing on an enrollee in a health plan a 
27 copayment or other charge that exceeds the cost of the medication. The amendment also 
28 prohibits a carrier or pharmacy benefits manager from penalizing a pharmacy provider for 
29 disclosing relevant information about the cost or clinical efficacy of a medication to an 
30 enrollee. 
Page 1 -128LR0193(02)-1 
COMMITTEE AMENDMENT 
